Success Story: NIW Approval for a Ph.D. Researcher With Our Expert Guidance and Strategic Filing
Client’s Testimonial:
"Thank you for your support throughout this journey.”
On December 9th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Post Doc in the Field of Bio-analytical Chemistry (Approval Notice).
General Field: Bio-analytical Chemistry
Position at the Time of Case Filing: Post Doc
Country of Origin: Sri Lanka
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: December 9th, 2025
Processing Time: 3 months, 28 days
Case Summary:
The persuasiveness of an NIW case relies on establishing a clear link between past achievements and future national value. That was exactly the strength of this I-140 NIW-approved case. Our client, a Ph.D. in chemistry, presented a focused and forward-looking endeavor in bio-analytical chemistry, supported by a publication record, independent citation evidence, expert endorsements, and research funding that together showed she was well-positioned to continue advancing work of clear importance to the United States.
The client proposed to continue research on developing cutting-edge and affordable biosensors, lab-grown human organoids, and organ-on-a-chip systems that mimic human organs and rapidly detect disease-specific biomarkers. The broader aim of this work is to decode the biology of emerging diseases and enable earlier and more accurate diagnoses. The petition also documented that she is currently conducting research in the field at a U.S. medical school, where her ongoing work includes studying paraspeckles, immune cell activation, and disease-related cellular function using molecular and imaging techniques. That current role helped confirm both continuity in the field and the client’s practical capacity to keep advancing the proposed endeavor.
We also showed that the client was well-positioned to carry this work forward. She had authored 5 peer-reviewed journal articles and 5 conference abstracts, including multiple co-first-authored and first-authored works. In an NIW case, those numbers are most persuasive when they show a pattern of meaningful, peer-vetted output rather than simple quantity. Here, the petition emphasized that her work appeared in highly ranked publication venues in the field, which helps an adjudicator see that her research had already passed a notable level of scientific scrutiny and recognition.
Citation evidence added another important layer. The client’s publications had been cited 34 times, and the petition did not treat that figure as self-explanatory. Instead, it explained that other researchers had relied on her findings in areas such as biomarker technologies, smartphone-assisted disease detection, and antibody immobilization techniques.
Another helpful feature of the case was the funding record. The petition included evidence of support from the National Science Foundation, which served as an objective signal that the broader research direction aligned with nationally important scientific and health-related priorities. In NIW cases, funding evidence can strengthen the record because it shows that respected institutions have already invested in the underlying value of the work.
The petition also included 2 letters of recommendation from experts in the field. These letters helped reinforce the client’s scientific skill set, the novelty of her research, and her ability to continue contributing to bio-analytical chemistry in ways that matter beyond a single project or institution. They were especially helpful in explaining the broader implications of the client’s work in practical terms for a non-specialist adjudicator. One expert noted: “Given the urgent need to encourage translational innovation pipelines, [Client’s] continued research remains to both industry and academia in the U.S.”
We are delighted to share that the client’s I-140 NIW petition was approved. It was a privilege to support a case built around innovative diagnostic technologies, strong evidence of peer reliance, and a clear showing that the client’s future work could advance U.S. interests in public health and biomedical research. We extend our sincere congratulations and best wishes for the client’s continued success.